Pharma in Focus - knowledge in power
8 - 14 Mar 2010
 
Analysis: HTA changes, more bureaucracy or faster to market?
By July this year the pharmaceutical industry may be facing a new layer of bureaucracy in making market approval reimbursement submissions but there is also hope those submissions will move faster
R&D trend means a challenging trials environment
This week the trend for major pharma companies to re-examine their commitment to R&D came into sharp focus again as AstraZeneca announced where it would implement R&D cuts revealed in general terms some weeks before
About Pharma in Focus

Pharma in Focus is Australia 's only independent pharma industry news service.

We deliver up-to-date, in-depth news, analysis and opinion straight to your desktop 48 times a year, covering the whole pharma sector, both prescription and non-prescription in Australia and New Zealand.

Who is Pharma in Focus for?
  • People in all pharmacos, including:
    • Marketing
    • Sales
    • Medical
    • Regulatory affairs
    • Communications and media
    • Strategy and planning
    • C level executives
  • People in businesses that serve pharma, including:
    • Public relations agencies
    • Advertising agencies
    • Market researchers
    • Medical media
    • Financial analysts
    • Lawyers
    • CROs
  • People in organisations that relate to pharma, including:
    • Government departments
    • Non-government organisations
    • Research institutes
    • Biotech ventures
    • Industry bodies

How will I benefit from Pharma in Focus?

  • Pharma in Focus will:
    • Save you time
    • Save you effort
    • Keep you in front
    • Put you in control

How does Pharma in Focus deliver these benefits?

Pharma in Focus is your one stop shop for pharma industry intelligence.

  • We cover:
    • Government and the Bureaucracy
    • Regulatory and Legal Affairs
    • GP, Specialist & Pharmacist Activities
    • Marketing, Media & Corporate Affairs
    • Employment
    • Industry & Research (including Biotech)
  • We talk to, quote, publish and keep tabs on:
    • Heavyweight regulators
    • Industry leaders
    • Top bureaucrats
    • Marketing gurus
    • Conference speakers
    • Leading researchers
    • Government ministers
    • Recruitment experts
  • We deliver:
    • News
    • Analysis
    • Comment
    • 48 times a year
    • PLUS breaking news updates

How do I get Pharma in Focus?

We email Pharma in Focus straight to your desktop every week (48 times a year).

You can choose the News Alert only service (free subscription) or the News Alert with Full Text (paid subscription).

The News Alert only service delivers:

  • News headlines
  • Single paragraph story briefs
  • Update on industry staff movements
  • Job listings
  • Commercial services directory

The News Alert with Full Text delivers all the above plus:

  • Full length news stories
  • Breaking news updates
  • In-depth analysis of industry issues
  • Commentary from industry leaders
  • Advisory features written by recognised industry experts
  • Full archive search facility covering hundreds of Pharma in Focus articles
  • Email to a colleague for individual articles

Full Text FREE Trial – to trial our Full Text service free for two issues, click here

Who's behind Pharma in Focus ?

Pharma in  Focus is published by Lush Media and edited by Nick Lush, former  editor of Medical Observer, voted Australia's top business to  business publication in 2002.

Nick has been in journalism for over 20 years. He possesses specialised expertise in health, research, finance and political reporting and editing.

He has an extensive knowledge of the pharmaceutical industry in Australia and its relationships with government and the private sector.

TOP | BACK

 

Welcome Guest
Instant Update: Thurs 11 March
..full report
Vioxx claims in hundreds of millions
..full report
Generic fines well below MA levels
..full report
PBAC's last fee-free meeting
..full report
Amgen, Hospira in patent wrangle
..full report
Backlog distorts PBS statistics
..full report
Combos stopped osteo drug decline
..full report
Reckitt fights back on Nurofen Plus
..full report
IT bungle delays PI, CMI capture
..full report

© 2007 Lush Media | Privacy Statement | Subscribe to Pharma in Focus